Stroke risk factor, pattern and outcome in patients with cancer

Acta Neurologica Scandinavica

Volumn 114, Issue 6, 2006, Pages 378-383

  Zhang, Y Y ^a,b   Chan, D K Y ^b,c   Cordato, D ^b   Shen, Q ^b   Sheng, A Z ^b  

^a Shanghai Yueyang Hospital of Chinese and Western Medicine   (China)

^b BANKSTOWN LIDCOMBE HOSPITAL   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Cancer; Coagulation; Outcome; Risk factors; Stroke

Indexed keywords

PROTHROMBIN;

AGED; ARTICLE; BLOOD CLOTTING DISORDER; BRAIN HEMORRHAGE; CANCER PATIENT; COLON CANCER; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; DEATH; DEEP VEIN THROMBOSIS; FEMALE; HOSPITAL ADMISSION; HUMAN; LUNG CANCER; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MELANOMA; OUTCOME ASSESSMENT; PARTIAL THROMBOPLASTIN TIME; PROSTATE CANCER; PROTHROMBIN TIME; RETROSPECTIVE STUDY; RISK FACTOR; STROKE; STROKE PATIENT;

AGED; AGED, 80 AND OVER; AUSTRALIA; BLOOD COAGULATION TESTS; BRAIN ISCHEMIA; CASE-CONTROL STUDIES; CEREBROVASCULAR ACCIDENT; FEMALE; HUMANS; INTRACRANIAL HEMORRHAGES; MALE; NEOPLASMS; RISK FACTORS; TREATMENT OUTCOME;

EID: 33750609827     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2006.00709.x     Document Type: Article

References (21)

1. GRAUS F, ROGERS LR, POSNER JB. Cerebrovascular complications in patients with cancer. Medicine 1985;64:16-35.
2. NILSSON G, HOLMBERG L, GARMO H, TERENT A, BLOMQVIST C. Increased incidence of stroke in women with breast cancer. Eur J Cancer 2005;41:423-9.
3. SUDLOW CL, WARLOW CP. Comparable studies of the incidence of stroke and its pathological types: results from an international collaboration. International Stroke Incidence. Stroke 1997;28:491-9.
4. KITAMURA A, ISO H, IIDA M et al. Trends in the incidence of coronary heart disease and stroke and the prevalence of cardiovascular risk factors among Japanese men from 1963 to 1994. Am J Med 2002;112:104-9.
5. INTISO D, STAMPATORE P, ZARRELLI MM et al. Incidence of first-ever ischaemic and hemorrhagic stroke in a well-defined community of southern Italy, 1993-1995. Eur J Neurol 2003;10:559-65.
6. CESTARI DM, WEINE DM, PANAGEAS KS, SEGAL AZ, DEANGELIS LM. Stroke in patients with cancer: incidence and aetiology. Neurology 2004;62:2025-30.
7. AMICO L, CAPLAN LR, THOMAS C. Cerebrovascular complications of mucinous cancers. Neurology 1989;39:522-6.
8. PACKER RJ, RORKE LB, LANGE BJ, SIEGEL KR, EVANS AE. Cerebrovascular accidents in children with cancer. Pediatrics 1985;76:194-201.
9. O'NEILL BP, DINAPOLI RP, OKAZAKI H. Cerebral infarction as a result of tumour emboli. Cancer 1987;60:90-5.
10. LEFKOVITZ NW, ROESSMANN U, KORI SH. Major cerebral infarction from tumour embolus. Stroke 1986;17:555-7.
11. ROGERS LR. Cerebrovascular complications in cancer patients. Neurol Clin 2003;21:167-92.
12. National Centre for Classification in Health. The international statistical classification of diseases and related health problems, 10th revision, Australian modification (ICD-10-AM). Australia: National Centre for Classification in Health, 2004.
13. LAI SM, DUNCAN PW. Stroke recovery profile and the modified Rankin assessment. Neuroepidemiology 2001;20:26-30.
14. ADAMS HP JR, BENDIXEN BH, KAPPELLE LJ. Classification of subtype of acute ischaemic stroke. Definitions for use in a multicenter clinical trial. TOAST Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993;24:35-41.
15. CHATURVEDI S, ANSELL J, RECHT L. Should cerebral ischaemic events in cancer patients be considered a manifestation of hypercoagulability? Stroke 1994;25:1215-8.
16. KARAPANAYIOTIDES TH, PIECHOWSKI-JOZWIAK B, VAN MELLE G, BOGOUSSLAVSKY J, DEVUYST G. Stroke patterns, aetiology, and prognosis in patients with diabetes mellitus. Neurology 2004;62:1558-62.
17. LIEU AS, HWANG SL, HOWNG SL, CHAI CY. Brain tumour with haemorrhage. J Formos Med Assoc 1999;98:365-7.
18. KOO S, KUCHER N, NGUYEN PL, FANIKOS J, MARKS PW, GOLDHABER SZ. The effect of excessive anticoagulation on mortality and morbidity in hospitalized patients with anticoagulant-related major haemorrhage. Arch Intern Med 2004;164:1557-60.
19. WOJTUKIEWICZ MZ, SIERKO E, ZACHARSKI LR, ZIMNOCH L, KUDRYK B, KISIEL W. Tissue factor-dependent coagulation activation and impaired fibrinolysis in situ in gastric cancer. Semin Thromb Hemost 2003;329:291-300.
20. KOHLI M, KAUSHAL V, MEHTA P. Role of coagulation and fibrinolytic system in prostate cancer. Semin Thromb Hemost 2003;329:301-8.
21. CAINE GJ, STONELAKE PS, LIP GY, KEHOE ST. The hypercoagulable state of malignancy: pathogenesis and current debate. Neoplasia 2002;4:465-73.